Published in J Miss State Med Assoc on May 01, 2014
Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci U S A (2002) 1.66
In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci (2007) 1.52
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J (2005) 1.51
Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: a case-control study. Int J Cancer (2012) 1.48
Hierarchical assembly of beta2-microglobulin amyloid in vitro revealed by atomic force microscopy. J Mol Biol (2003) 1.39
Remoteness of residence and survival from cancer in New South Wales. Med J Aust (2004) 1.33
Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study. BMC Health Serv Res (2011) 1.19
Stacked sets of parallel, in-register beta-strands of beta2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling. J Biol Chem (2010) 1.17
Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality. Med J Aust (2009) 1.09
Cancer screening among migrants in an Australian cohort; cross-sectional analyses from the 45 and Up Study. BMC Public Health (2009) 1.03
Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide. Biophys J (2007) 0.98
Risk factors for erectile dysfunction in a cohort of 108 477 Australian men. Med J Aust (2013) 0.95
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 0.93
Role of the N and C-terminal strands of beta 2-microglobulin in amyloid formation at neutral pH. J Mol Biol (2003) 0.93
Parental pregnancy intention and early childhood stunting: findings from Bolivia. Int J Epidemiol (2004) 0.93
Dimeric structures of alpha-synuclein bind preferentially to lipid membranes. Biochim Biophys Acta (2008) 0.92
Clinicians' attitudes to prostate cancer peer-support groups. BJU Int (2006) 0.91
Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes Control (2004) 0.90
Linker histone H1 binds to disease associated amyloid-like fibrils. J Mol Biol (2006) 0.90
Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation. Aust N Z J Public Health (2008) 0.89
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007. Cancer Epidemiol (2013) 0.87
Characteristics of cases with unknown stage prostate cancer in a population-based cancer registry. Cancer Epidemiol (2013) 0.87
Projecting prevalence by stage of care for prostate cancer and estimating future health service needs: protocol for a modelling study. BMJ Open (2011) 0.86
Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. BMC Public Health (2013) 0.84
Psychometric properties of the DSM scale for depression (DSD) with Korean-American youths. Issues Ment Health Nurs (2002) 0.84
Prostate-specific antigen levels in men aged 70 years and over: findings from the CHAMP study. Med J Aust (2012) 0.83
Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States. J Am Soc Mass Spectrom (2013) 0.83
Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia. BJU Int (2015) 0.83
The impact of pregnancy intention on breastfeeding duration in Bolivia and Paraguay. Stud Fam Plann (2007) 0.83
Study of receptor-chaperone interactions using the optical technique of spectroscopic ellipsometry. Biophys J (2011) 0.82
A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia. Int Urol Nephrol (2014) 0.80
Quantification of ligand binding to G-protein coupled receptors on cell membranes by ellipsometry. PLoS One (2012) 0.80
Recombinant " IMS TAG" proteins--a new method for validating bottom-up matrix-assisted laser desorption/ionisation ion mobility separation mass spectrometry imaging. Rapid Commun Mass Spectrom (2013) 0.80
A randomised controlled trial of the Flinders Program™ of chronic condition management in Vietnam veterans with co-morbid alcohol misuse, and psychiatric and medical conditions. Aust N Z J Psychiatry (2013) 0.80
Impact of Australian celebrity diagnoses on prostate cancer screening. Med J Aust (2009) 0.79
Skin cancer in general practice --impact of an early detection campaign. Aust Fam Physician (2007) 0.79
Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocol. Implement Sci (2014) 0.79
Analysis of protein interactions at native chloroplast membranes by ellipsometry. PLoS One (2012) 0.78
The association of ultraviolet radiation-B (305 nm), season of diagnosis, and latitude on the survival outcome of prostate cancer in the high UV environment of Australia. Cancer Causes Control (2013) 0.78
A randomised controlled trial of a mindfulness intervention for men with advanced prostate cancer. BMC Cancer (2013) 0.77
Laparoscopic simulation for all: two affordable, upgradable, and easy-to-build laparoscopic trainers. J Surg Educ (2013) 0.76
Geographic disparities in prostate cancer outcomes--review of international patterns. Asian Pac J Cancer Prev (2015) 0.75
Analysis of Abeta interactions using ProteinChip technology. Methods Mol Biol (2008) 0.75
The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia. Aust N Z J Public Health (2014) 0.75
The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: the CHAMP study. World J Urol (2013) 0.75